Label Update for Viloxazine ER: New Pharmacodynamic Data and Breastfeeding Info
January 27, 2025
The FDA has approved an update for the label for viloxazine ER to n...
Read More
APA Updates Guidance on Borderline Personality Disorder
January 15, 2025
The American Psychiatric Association (APA) recently released update...
Read More
Effectiveness of Antidepressant Treatments In TRD
January 10, 2025
A comprehensive network meta-analysis recently published offers new...
Read More
FDA Approves Tirzepatide for Adults with Obstructive Sleep Apnea and Obesity
December 21, 2024
The FDA has approved tirzepatide for adults with moderate-to-severe...
Read More
Brexpiprazole and Sertraline Combination Therapy Improves PTSD Symptoms
December 18, 2024
Results from a phase III clinical trial indicated that a combinati...
Read More
Antipsychotic Polypharmacy on the Rise
December 16, 2024
Antipsychotic polypharmacy remains a common practice despite eviden...
Read More
Prevalence of ADHD in Adulthood
December 5, 2024
Despite the widespread prevalence of ADHD in adulthood, many patien...
Read More
Increase in Postpartum Depression Rates
November 22, 2024
A recent study revealed a rise in postpartum depression (PPD) over ...
Read More
Recall of Clonazepam Orally Disintegrating Tablets Expands
November 19, 2024
Voluntary recall of clonazepam orally disintegrating tablets has be...
Read More
GLP-1 Agonist for Alcohol Use Disorder
November 16, 2024
A new study suggests that glucagon-like peptide-1 receptor (GLP-1) ...
Read More
Alzheimer's Disease Awareness
November 13, 2024
During National Alzheimer’s Disease Awareness Month we’d like to hi...
Read More
Glutamatergic Modulation for Psychiatric Disorders
November 10, 2024
he science behind the role of glutamatergic neurotransmissions role...
Read More